TPCW
TECH icon

TD Private Client Wealth’s Bio-Techne TECH Stock Holding History

TD Private Client Wealth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Sell
193
-91
-32% -$4.91K ﹤0.01% 1088
2026
Q1 		$14.8K Buy
284
+13
+5% +$780 ﹤0.01% 1053
2025
Q4 		$15.9K Sell
271
-14
-5% -$851 ﹤0.01% 1040
2025
Q3 		$15.9K Buy
285
+228
+400% +$12.2K ﹤0.01% 1014
2025
Q2 		$2.93K Sell
57
-256
-82% -$12.9K ﹤0.01% 1179
2025
Q1 		$18.4K Sell
313
-124
-28% -$8.4K ﹤0.01% 947
2024
Q4 		$31.5K Hold
437
– – ﹤0.01% 904
2024
Q3 		$34.9K Sell
437
-20
-4% -$1.5K ﹤0.01% 893
2024
Q2 		$32.7K Sell
457
-11
-2% -$810 ﹤0.01% 877
2024
Q1 		$32.9K Hold
468
– – ﹤0.01% 883
2023
Q4 		$36.1K Buy
468
+388
+485% +$25.6K ﹤0.01% 868
2023
Q3 		$5.45K Sell
80
-33
-29% -$2.61K ﹤0.01% 1111
2023
Q2 		$9.22K Buy
113
+55
+95% +$4.42K ﹤0.01% 1063
2023
Q1 		$4.3K Sell
58
-6
-9% -$462 ﹤0.01% 1114
2022
Q4 		$5.3K Sell
64
-124
-66% -$9.85K ﹤0.01% 1070
2022
Q3 		$13.3K Buy
188
+148
+370% +$12.8K ﹤0.01% 965
2022
Q2 		$3.47K Sell
40
-88
-69% -$8.25K ﹤0.01% 1094
2022
Q1 		$13.9K Sell
128
-1,740
-93% -$180K ﹤0.01% 1000
2021
Q4 		$242K Buy
1,868
+20
+1% +$2.45K 0.01% 523
2021
Q3 		$224K Buy
1,848
+16
+0.9% +$1.95K 0.01% 509
2021
Q2 		$206K Hold
1,832
– – 0.01% 515
2021
Q1 		$175K Sell
1,832
-116
-6% -$10.6K 0.01% 518
2020
Q4 		$155K Sell
1,948
-28
-1% -$2.03K 0.01% 511
2020
Q3 		$122K Buy
1,976
+1,920
+3,429% +$125K 0.01% 510
2020
Q2 		$3.7K Hold
56
– – ﹤0.01% 858
2020
Q1 		$2.65K Hold
56
– – ﹤0.01% 857
2019
Q4 		$3.07K Buy
+56
New +$2.94K ﹤0.01% 867

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TD Private Client Wealth's TECH Position: Q2 2026 in Review

TD Private Client Wealth reduced its Bio-Techne (TECH) stake by 32% in Q2 2026, selling an estimated $4.91K and leaving 193 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

TD Private Client Wealth first reported a position in TECH in Q4 2019 and has held it in 27 quarters since. The position peaked at $242K in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • TD Private Client Wealth held 193 shares of Bio-Techne worth $13.6K as of Q2 2026.
  • TD Private Client Wealth sold 91 Bio-Techne shares in Q2 2026, an estimated $4.91K.
  • Bio-Techne made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1088 holding.
  • TD Private Client Wealth first reported a position in Bio-Techne in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Bio-Techne position peaked at $242K in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.